Down Syndrome Market
Oct 30, 2020
Which pipeline therapy has the potential to revolutionize the Down Syndrome Market?
Everyone can think that extra add-ons to the living may change the lifestyles. Is the leverage similar in life with an extra-chromosome?? The answer is, No! Take the case of Down syndrome (DS) that has an extra copy of chromosome 21 and associated higher societal costs with physical changes and intellectual disa...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
